Hile BioPharmaceutical Overview

  • Status
  • Public
  • Employees
  • 518
  • Stock Symbol
  • 603718
Stock Symbol
  • Investments
  • 2
  • Share Price
  • $2.08
  • (As of Friday Closing)

Hile BioPharmaceutical General Information


Shanghai Hile Bio-Technology Co Ltd is a veterinary biological product manufacturer integrating research and development, production, sales, and service. The company has over 40 categories of poultry, livestock, and pets. The company provides services for the prevention of livestock diseases, improving the health of livestock and poultry, and improving the production efficiency of farmers, and is able to provide comprehensive solutions and an authoritative veterinary expert service system.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Stock Exchange
Primary Office
  • Jinhai Lu, No. 6720
  • Shanghai, 201403
  • China
+86 00000000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Hile BioPharmaceutical Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.08 $2.14 $1.54 - $3.93 $1.34B 644M 6.63M

Hile BioPharmaceutical Financials Summary

In Thousands,
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 1,391,042 1,150,540 1,095,532 1,186,211
Revenue 46,550 37,508 40,233 38,481
EBITDA 13,248 7,587 11,954 10,118
Net Income 5,049 1,292 1,759 3,220
Total Assets 274,942 273,483 243,152 254,190
Total Debt 0 0 0 7,268
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Hile BioPharmaceutical Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Hile BioPharmaceutical‘s full profile, request access.

Request a free trial

Hile BioPharmaceutical Executive Team (1)

Name Title Board Seat Contact Info
Haiming Zhang Chairman
To view Hile BioPharmaceutical’s complete executive team members history, request access »

Hile BioPharmaceutical Board Members (4)

Name Representing Role Since
Haiming Zhang Hile BioPharmaceutical Chairman 000 0000
Lianyong Chen Ph.D Self Board Member 000 0000
You’re viewing 2 of 4 board members. Get the full list »

Hile BioPharmaceutical Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hile BioPharmaceutical Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000000 12-Aug-2020 000000000 00.000 Biotechnology
Yikon Genomics 09-Sep-2016 Early Stage VC 000.00 Laboratory Services (Healthcare)
To view Hile BioPharmaceutical’s complete investments history, request access »